Amlaac® (Amla / Indian Gooseberry Extract)

Phyllanthus emblica
Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

Amlaac® is a standardized extract of amla (Phyllanthus emblica), the Indian gooseberry, one of the most revered fruits in Ayurveda. Exceptionally rich in vitamin C and polyphenols, amla is studied for supporting healthy cholesterol, blood sugar, and antioxidant status.

Studied Dose Commonly around 500 mg to 1 g per day.
Active Compound Standardized amla (Phyllanthus emblica / Emblica officinalis) fruit extract rich in vitamin C, gallic acid, and tannins.

Benefits

Healthy cholesterol

A meta-analysis of randomized trials found amla supported improvements in lipid profile, including total and LDL cholesterol.

Blood-sugar and inflammation support

The same analysis found amla supported healthier glucose and C-reactive protein (an inflammation marker).

Antioxidant defense

Amla is one of nature's richest sources of vitamin C and polyphenols, providing strong antioxidant protection.

Mechanism of action

1

Polyphenol and vitamin C antioxidants

Amla's gallic acid, tannins, and vitamin C scavenge free radicals and support the body's antioxidant systems.

2

Lipid and glucose modulation

Amla polyphenols support healthy cholesterol handling and blood-sugar metabolism.

Clinical trials

1
Amla and Cardiometabolic Markers — Meta-Analysis
PubMed

Systematic review and meta-analysis of randomized trials of amla (Emblica officinalis) on lipid profile, glucose, and C-reactive protein. (Setayesh et al. 2023, Diabetes and Metabolic Syndrome)

Adults across multiple RCTs.

Amla supported improvements in cholesterol, glucose, and inflammation markers versus control.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated — adverse effects are uncommon at normal doses.
Mild digestive upset is occasionally reported.
Discontinue if any unusual reaction occurs.

Important Drug interactions

Diabetes medication — amla may lower blood sugar; monitor.
Anticoagulants — possible mild additive effect; monitor.
Tell your doctor if you take cholesterol or diabetes medication.

Frequently asked questions about Amlaac® (Amla / Indian Gooseberry Extract)

What is Amlaac?

Amlaac® is a standardized extract of amla (Phyllanthus emblica), the Indian gooseberry, one of the most revered fruits in Ayurveda. Exceptionally rich in vitamin C and polyphenols, amla is studied for supporting healthy cholesterol, blood sugar, and antioxidant status.

What is Amlaac used for?

Amlaac is researched primarily for Antioxidant, Cardiovascular, and Metabolic Health. A meta-analysis of randomized trials found amla supported improvements in lipid profile, including total and LDL cholesterol.

What is the recommended dosage of Amlaac?

The clinically studied dose is Commonly around 500 mg to 1 g per day. Always follow the product label and check with a healthcare provider for personal advice.

Is Amlaac safe, and does it have side effects?

For most healthy adults, Amlaac is well tolerated at studied doses. Reported effects can include: Generally well-tolerated — adverse effects are uncommon at normal doses. Mild digestive upset is occasionally reported. It may also interact with some medications. Amlaac is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Amlaac interact with any medications?

Possible interactions include: Diabetes medication — amla may lower blood sugar; monitor. Anticoagulants — possible mild additive effect; monitor. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Amlaac?

NutraSmarts rates the evidence for Amlaac as Moderate (3 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Setayesh L, Haghighat N, Rasaei N, et al. The impact of Emblica Officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr. 2023;17(3):102729..PubMedUsed to support: Meta-analysis supporting cardiometabolic benefit of amla.